After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Standard BioTools Inc is listed on the NASDAQ in the Healthcare sector while operating in the Medical Devices industry. The current market capitalization of Standard BioTools Inc is $447.21M. A total of 1.28 million shares were traded on the day, compared to an average of 1.94M shares.
In the most recent transaction, Casdin Partners Master Fund, L bought 4,820,959 shares of LAB for 1.06 per share on Feb 28 ’25. After the transaction, the Director now owns 58,846,780 company shares. In a previous transaction on Nov 12 ’24, Black Jeffrey G. bought 57,971 shares at 2.12 per share.
Among the insiders who bought shares, Taich Adam acquired of 45,851 shares on Sep 09 ’24 at a per-share price of $2.00. In another insider transaction, Casdin Partners Master Fund, L bought 250,000 shares at $2.19 per share on Aug 27 ’24. Company shares held by the Director now total 54,025,821.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, LAB has a high of $3.04 and a low of $0.99.
As of this writing, LAB has an earnings estimate of -$0.04 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.04 per share and a lower estimate of -$0.04.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. LAB’s latest balance sheet shows that the firm has $28.45M in Cash & Short Term Investments as of fiscal 2021. There were $111.65M in debt and $49.57M in liabilities at the time. Its Book Value Per Share was $1.25, while its Total Shareholder’s Equity was $94.60M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for LAB is Buy with a score of 4.33.
